a massive sell off, page-102

I am comfortable with u in the SRX thread, TeTeTe. But stick around, please, 2morrow might be quite a day for shorters, if you were a trader and going to sell, you would have sold 2day, this probably explains the late day slide from foreign fundies waking up to the news. Fundamentals and the trial results r still good for SRX, just not the colorectal primary treatment.
T/A suggests that if volumes remain like 2day or go down, it will eventually retrace to about $26-$28.
My FV has been high 20s for this stock for some time.
If the clinical trials r believable, it might go back to the $30s, only based on fundamentals, not the T/A which doesn't support marks above $28.